Akebia Therapeutics

๐Ÿ“ Cambridge, United States๐Ÿ—“ Founded 2007๐Ÿ‘ฅ 263 employees๐Ÿ’ฐ Last funded Sep 2014
Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2007
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Akebia Therapeutics?
Akebia Therapeutics has 2 investors on record on gritt.io and 2 late-stage investors.
When did Akebia Therapeutics last raise funding?
The most recent investment in Akebia Therapeutics recorded on gritt.io was in September 2014.
When was Akebia Therapeutics founded?
Akebia Therapeutics was founded in 2007.
What industry is Akebia Therapeutics in?
Akebia Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Akebia Therapeutics based?
Akebia Therapeutics is headquartered in Cambridge, United States.